查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607987

疱疹标记测试市场：按适应症、测试类型和应用划分 - 2025-2030 年全球预测

Herpes Marker Testing Market by Indication (HSV-1, HSV-2), Test Type (Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, Viral Culture Test), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，疱疹标记检测市场价值为4.6822亿美元，预计到2024年将达到4.9786亿美元，复合年增长率为6.46%，到2030年将达到7.2583亿美元。

单纯疱疹病毒 (HSV) 感染透过检测生物样本中的病毒抗原和抗体的临床检测来识别和管理。全球 HSV感染疾病的高盛行率、及时准确的诊断以进行有效的疾病管理以及对个人化医疗的需求不断增长，推动了对疱疹标记物检测的需求。应用范围从医疗机构的常规诊断业务到旨在了解病毒流行病学和开发疫苗的研究和开发。最终用户主要是医院、诊断实验室和研究机构。市场成长受到分子检测技术进步、性行为感染感染（STI）意识提高以及医疗保健支出增加等因素的影响。然而，成长面临的挑战包括先进诊断系统的高成本、资源匮乏地区的有限就地检验以及与性传染感染相关的社会耻辱，这些都阻碍了人们得到诊断。新的商机在于在医疗保健基础设施正在开发的发展中地区扩大检测服务，以及旨在提高检测准确性和缩短获得结果的时间的持续研发工作。企业可以利用家庭检测套组和数位健康平台的不断增长趋势进行远距离诊断。然而，监管监督以及对测试结果的高特异性和敏感性的需求仍然是重要的障碍。该领域的创新可集中于开发适合家庭使用的经济高效、快速出结果的检测套组，以及整合人工智慧以进行预测诊断和个人化治疗计划。市场竞争处于中度和高度活跃状态，永续成长需要策略伙伴关係和持续创新。整体而言，有针对性的研发投资和策略性市场扩大策略将是利用未来成长机会同时克服现有挑战的关键。

主要市场统计
基准年[2023] 46822万美元
预计年份 [2024] 4.9786 亿美元
预测年份 [2030] 72583万美元
复合年增长率（%） 6.46%

市场动态：揭示快速发展的疱疹标记测试市场的关键市场洞察

供需的动态交互作用正在改变疱疹标记物检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人群中疱疹感染的盛行率
    • 提高对口腔和生殖器感染的早期诊断和治疗的认识
    • 增加医疗支出并改善医疗基础设施
  • 市场限制因素
    • 由于缺乏技术人员而缺乏测试实验室
  • 市场机会
    • 介绍新开发的疱疹检测套组
    • 增加治疗疱疹感染疾病的新疫苗的研究活动
  • 市场挑战
    • 核准过程艰难且漫长

波特的五力：驾驭疱疹标记物测试市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对疱疹标记检测市场的影响

外部宏观环境因素在塑造疱疹标记测试市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解疱疹标记物检测市场的竞争状况

对疱疹标记物测试市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵疱疹标记检测市场供应商绩效评估

FPNV定位矩阵是评估疱疹标记物检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了疱疹标誌物测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，疱疹标记测试市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中疱疹感染的盛行率
      • 提高对口腔和生殖器感染疾病的早期诊断和治疗的认识
      • 医疗成本上升和医疗基础设施改善
    • 抑制因素
      • 实验室数量有限，缺乏熟练的人力资源。
    • 机会
      • 介绍新开发的疱疹检测套组
      • 治疗疱疹感染疾病的新疫苗的研究活动活性化
    • 任务
      • 严格而漫长的核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 疱疹标记测试市场（按适应症）

  • HSV-1
  • HSV-2

第七章按测试类型分類的疱疹标记测试市场

  • 基于抗体或抗原的套件
  • 基于核酸扩增的套件
  • 病毒培养测试

第八章疱疹标记测试市场：按应用分类

  • 临床
  • 调查

第九章 北美和南美疱疹标记检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区疱疹标记检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲疱疹标记检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Abcam PLC
  • AdvaCare Pharma
  • Bio-Diagnostics Ltd.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Biopanda Reagents Ltd.
  • CTK Biotech, Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Genome Diagnostics Pvt. Ltd.
  • Hologic, Inc.
  • InTec PRODUCTS, INC.
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • Norgen Biotek Corporation
  • QED Bioscience, Inc.
  • Qiagen NV
  • Quidel Corporation
  • Rapid STD Testing by RSC Health, PA
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-DD0700E81D12

The Herpes Marker Testing Market was valued at USD 468.22 million in 2023, expected to reach USD 497.86 million in 2024, and is projected to grow at a CAGR of 6.46%, to USD 725.83 million by 2030.

Herpes marker testing is a crucial segment within the broader diagnostic testing market, focused on identifying and managing herpes simplex virus (HSV) infections through clinical assays that detect viral antigens or antibodies in biological samples. The necessity for herpes marker testing is driven by the high prevalence of HSV infections globally, the need for timely and accurate diagnosis for effective disease management, and the rising demand for personalized medicine. Applications range from routine diagnostic practices in healthcare facilities to research explorations aimed at understanding the virus's epidemiology and developing vaccines. End-users primarily include hospitals, diagnostic laboratories, and research institutions. Market growth is influenced by factors like advancements in molecular testing technologies, increasing awareness about sexually transmitted infections (STIs), and rising healthcare expenditure. However, challenges to growth include the high costs of advanced diagnostic systems, limited availability of point-of-care testing in low-resource regions, and social stigma associated with STIs hindering individuals from seeking diagnosis. Emerging opportunities lie in the expansion of testing services in developing regions with improving healthcare infrastructure and the ongoing R&D efforts to enhance test precision and reduce time-to-result. Companies can capitalize on the growing trend towards home-based testing kits and digital health platforms for remote diagnosis. However, regulatory scrutiny and the need for high specificity and sensitivity in test results remain critical barriers. Innovation in this space could focus on developing cost-effective, rapid-result test kits suitable for home use and integrating artificial intelligence for predictive diagnosis and personalized treatment plans. The market is dynamic with moderate to high competition, requiring strategic partnerships and continuous innovation for sustained growth. Overall, targeted investment in R&D, coupled with strategic market expansion strategies, will be key to capitalizing on future growth opportunities while navigating existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 468.22 million
Estimated Year [2024] USD 497.86 million
Forecast Year [2030] USD 725.83 million
CAGR (%) 6.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Herpes Marker Testing Market

The Herpes Marker Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of herpes infections among population
    • Growing awareness of early diagnosis and treatments of oral and genital infection
    • Rising healthcare spendings and improved healthcare infrastructure
  • Market Restraints
    • Limited availability of laboratories along with lack of skilled personnel
  • Market Opportunities
    • Introduction of newly developed herpes testing kits
    • Growing research activities for novel vaccines to treat herpes infections
  • Market Challenges
    • Stringent and time consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Herpes Marker Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Herpes Marker Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Herpes Marker Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Herpes Marker Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Herpes Marker Testing Market

A detailed market share analysis in the Herpes Marker Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Herpes Marker Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Herpes Marker Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Herpes Marker Testing Market

A strategic analysis of the Herpes Marker Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Herpes Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, AdvaCare Pharma, Bio-Diagnostics Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Biopanda Reagents Ltd., CTK Biotech, Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Genome Diagnostics Pvt. Ltd., Hologic, Inc., InTec PRODUCTS, INC., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor, Inc., Norgen Biotek Corporation, QED Bioscience, Inc., Qiagen N.V., Quidel Corporation, Rapid STD Testing by RSC Health, PA, Teco Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Herpes Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across HSV-1 and HSV-2.
  • Based on Test Type, market is studied across Antibody or Antigen-based Kits, Nucleic Acid Amplification based Kits, and Viral Culture Test.
  • Based on Application, market is studied across Clinical and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of herpes infections among population
      • 5.1.1.2. Growing awareness of early diagnosis and treatments of oral and genital infection
      • 5.1.1.3. Rising healthcare spendings and improved healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of laboratories along with lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newly developed herpes testing kits
      • 5.1.3.2. Growing research activities for novel vaccines to treat herpes infections
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent and time consuming approval processes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Herpes Marker Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. HSV-1
  • 6.3. HSV-2

7. Herpes Marker Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Antibody or Antigen-based Kits
  • 7.3. Nucleic Acid Amplification based Kits
  • 7.4. Viral Culture Test

8. Herpes Marker Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical
  • 8.3. Research

9. Americas Herpes Marker Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Herpes Marker Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Herpes Marker Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam PLC
  • 3. AdvaCare Pharma
  • 4. Bio-Diagnostics Ltd.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. Biopanda Reagents Ltd.
  • 8. CTK Biotech, Inc.
  • 9. DiaSorin S.p.A.
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. Genome Diagnostics Pvt. Ltd.
  • 12. Hologic, Inc.
  • 13. InTec PRODUCTS, INC.
  • 14. Merck KGaA
  • 15. Meridian Bioscience, Inc. by SD Biosensor, Inc.
  • 16. Norgen Biotek Corporation
  • 17. QED Bioscience, Inc.
  • 18. Qiagen N.V.
  • 19. Quidel Corporation
  • 20. Rapid STD Testing by RSC Health, PA
  • 21. Teco Diagnostics
  • 22. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. HERPES MARKER TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. HERPES MARKER TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HERPES MARKER TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HERPES MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HERPES MARKER TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY HSV-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY ANTIBODY OR ANTIGEN-BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION BASED KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY VIRAL CULTURE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HERPES MARKER TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES HERPES MARKER TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA HERPES MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM HERPES MARKER TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. HERPES MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. HERPES MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023